The present invention is directed to compounds of formula I. The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Parkinson's disease.
The present invention is directed to compounds of formula I. The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Parkinson's disease.
Krohs, Chemische Berichte, 1955, vol. 88, p. 866,871
作者:Krohs
DOI:——
日期:——
[EN] LRRK2 INHIBITORS<br/>[FR] INHIBITEURS DE LRRK2
申请人:[en]H. LUNDBECK A/S
公开号:WO2023073013A1
公开(公告)日:2023-05-04
The present invention is directed to compounds of formula I. The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Parkinson's disease.